The mechanism is that MYL9 binds to IQGAP1, regulates the secretion of CCL2 and TGF-β1 of CAFs through ERK 1/2, and these two cytokines promote the progression of CRC through PI3K-AKT pathway. Here, CCL2 is linked to colorectal carcinoma.